COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ)

Autor: Christopher S. Hayward, Gayathri Kumarasinghe, David M. Kaye, Priya Nair, Robert N. Doughty, Jo-Dee L. Lattimore, Sean Lal, Lawrence Dembo, Leonard Kritharides, Paul G. Bannon, Nicole K. Bart, Peter S. Macdonald, Máté Rudas, John Atherton, Clara K Chow, Carmine G. De Pasquale, George Javorsky, Robert G. Weintraub, Craig P. Juergens, Peter Bergin, Richard Totaro, Marcus Ilton
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Pulmonary and Respiratory Medicine
medicine.medical_specialty
ARDS
Consensus
Circulatory collapse
Myocarditis
Targeted transthoracic echocardiogram
Critical Illness
Pneumonia
Viral

Cardiology
Cardiomyopathy
030204 cardiovascular system & hematology
Article
Betacoronavirus
03 medical and health sciences
0302 clinical medicine
Intensive care
medicine
Humans
030212 general & internal medicine
Intensive care medicine
Acute cardiomyopathy
Pandemics
1102 Cardiorespiratory Medicine and Haematology
1117 Public Health and Health Services

Societies
Medical

Cause of death
Heart Failure
Infection Control
biology
SARS-CoV-2
business.industry
Australia
COVID-19
medicine.disease
Troponin
Patient Care Management
Coronavirus
Screening algorithm
Cardiovascular System & Hematology
Heart failure
biology.protein
Risk Adjustment
High sensitivity troponin
Coronavirus Infections
Cardiology and Cardiovascular Medicine
business
New Zealand
Zdroj: Heart, Lung & Circulation
Heart, Lung and Circulation
Popis: Up to one-third of COVID-19 patients admitted to intensive care develop an acute cardiomyopathy, which may represent myocarditis or stress cardiomyopathy. Further, while mortality in older patients with COVID-19 appears related to multi-organ failure complicating acute respiratory distress syndrome (ARDS), the cause of death in younger patients may be related to acute heart failure. Cardiac involvement needs to be considered early on in critically ill COVID-19 patients, and even after the acute respiratory phase is passing. This Statement presents a screening algorithm to better identify COVID-19 patients at risk for severe heart failure and circulatory collapse, while balancing the need to protect health care workers and preserve personal protective equipment (PPE). The significance of serum troponin levels and the role of telemetry and targeted transthoracic echocardiography (TTE) in patient investigation and management are addressed, as are fundamental considerations in the management of acute heart failure in COVID-19 patients.
Databáze: OpenAIRE